Calendar Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse 04:00:02 2024-06-07 pm EDT 5-day change 1st Jan Change
41.48 USD +1.47% Intraday chart for Bristol-Myers Squibb Company +0.95% -19.16%

Chart calendar Bristol-Myers Squibb Company

3dce0e6a18.CQWmWzk5BWnK1EHUoMpIBj0Ldbu7URMUNAyodR57MQk.R3SeAVprYCKT42yT6pgOfxBuI9ToA19kbF_tQngtU1pWSZN2QwBzLaiFEA~10d35372b9424f1f5deb6c09db618c10

Upcoming events on Bristol-Myers Squibb Company

2024-06-11 11:20 am Goldman Sachs Global Healthcare Conference
2024-06-14 09:45 am European Hematology Association Meeting - Abstract No #S235
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P1522
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P1516
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P1126
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P1132
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P1020
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P1034
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P749
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P780
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P785
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P763
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P774
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P789
2024-06-14 01:00 pm European Hematology Association Meeting - Abstract No #P782

Past events on Bristol-Myers Squibb Company

2024-06-04 10:45 am American Society of Clinical Oncology Meeting - Abstract No #LBA4008
2024-06-04 10:45 am American Society of Clinical Oncology Meeting - Abstract No #4000
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No #8522
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No #8560
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No #8610
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #7026
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #7068
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #7028
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #11105
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #6565
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #7529
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #7527
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #7047
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #7539
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No #7046
2024-06-03 10:00 am American Society Of Clinical Oncology Meeting - Abstract No #6522
2024-06-03 09:00 am American Society of Clinical Oncology Meeting - Abstract No #4507
2024-06-03 09:00 am American Society of Clinical Oncology Meeting - Abstract No #LBA8007
2024-06-03 09:00 am American Society of Clinical Oncology Meeting - Abstract No #4509
2024-06-02 05:30 pm American Society of Clinical Oncology Meeting - Abstract No #7010

Past dividends on Bristol-Myers Squibb Company

2024-04-03 Quarterly 0.6 USD
2024-01-03 Quarterly 0.6 USD
2023-10-04 Quarterly 0.57 USD
2023-07-05 Quarterly 0.57 USD
2023-04-05 Quarterly 0.57 USD
2023-01-04 Quarterly 0.57 USD
2022-10-05 Quarterly 0.54 USD
2022-06-29 Quarterly 0.54 USD
2022-03-30 Quarterly 0.54 USD
2022-01-05 Quarterly 0.54 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
26 145
26 418
-1.03%
42 518
42 189
0.78%
46 385
46 366
0.04%
46 159
45 911
0.54%
45 006
44 731
0.62%

46 088

EBITDA
Million USD
Released
Forecast
Spread
9 945
9 754
1.96%
18 118
20 279
-10.65%
20 493
21 878
-6.33%
20 123
20 368
-1.2%
17 498
18 255
-4.15%

5 170

EBIT
Million USD
Released
Forecast
Spread
8 199
8 540
-3.99%
17 426
17 664
-1.35%
19 830
19 963
-0.67%
19 442
18 924
2.73%
16 785
16 921
-0.8%

4 017

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
4 975
0,00
-
-6 871
1 541
-545.88%
8 098
7 644
5.94%
7 713
7 912
-2.51%
8 440
8 846
-4.59%

-5 696

Net income
Million USD
Released
Forecast
Spread
3 439
0,00
-
-9 015
1 269
-810.58%
6 994
6 219
12.46%
6 327
6 617
-4.39%
8 025
7 823
2.58%

-5 414

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
-3,99
0,53
-851.84%
3,12
2,78
12.07%
2,95
2,97
-0.55%
3,86
3,73
3.53%

-2,63

Announcement Date06/02/2004/02/2104/02/2202/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
11 648
11 343
2.69%
11 887
11 467
3.66%
11 218
11 180
0.34%
11 406
11 198
1.86%
11 337
11 498
-1.4%
11 226
11 811
-4.95%
10 966
10 959
0.06%
11 477
11 203
2.45%
11 865
11 451
3.62%

11 500


11 169


11 604


11 763


11 631

EBITDA
Million USD
Released
Forecast
Spread
5 305
5 176
2.5%
7 812
5 060
54.38%
7 424
4 973
49.29%
4 288
4 594
-6.66%
5 030
4 732
6.3%
4 268
6 031
-29.24%
4 539
5 339
-14.98%
3 816
4 833
-21.04%
-8 984
-8 394
-7.03%

4 264


4 424


4 694







EBIT
Million USD
Released
Forecast
Spread
5 267
4 848
8.63%
5 229
4 563
14.58%
4 836
4 622
4.62%
4 110
4 248
-3.26%
4 857
4 816
0.85%
4 251
4 785
-11.16%
4 360
4 206
3.66%
3 630
3 663
-0.91%
-8 329
-8 538
2.44%

4 142


4 041


4 196


4 906


4 630

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



1 958
2 118
-7.55%
2 209
2 139
3.27%
1 859
1 767
5.21%
2 770
2 808
-1.34%
1 859
2 836
-34.44%
2 137
2 216
-3.58%
1 674
2 000
-16.28%
-11 516



1 909


1 557


1 881







Net income
Million USD
Released
Forecast
Spread
1 278


1 421
1 423
-0.11%
1 606
1 469
9.33%
2 022
1 444
40.03%
2 262
2 290
-1.24%
2 073
2 165
-4.23%
1 928
1 585
21.63%
1 762
1 479
19.13%
-11 911
-10 359
-14.98%

1 390


1 336


2 563







EPS
USD
Released
Forecast
Spread
0,59
0,86
-31.4%
0,66
0,58
13.79%
0,75
0,71
5.63%
0,95
0,73
31.03%
1,07
1,19
-10.08%
0,99
1,16
-14.88%
0,93
0,89
4.03%
0,87
0,72
20.52%
-5,89
-4,84
-21.65%

0,81


0,78


1,25


1,82


1,70

Announcement Date29/04/2227/07/2225/10/2202/02/2327/04/2327/07/2326/10/2302/02/2425/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Calendar Bristol-Myers Squibb Company